AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

BriaCell Therapeutics Corp. Warrant

$0.13 -$0.11 (-46.94%)
NASDAQ · 14 Sep 2026 20:00 UTC
Previous Close
$0.14
Day Range
$0.12$0.13
Year Range
$0.13$0.13
Market Cap
244.89K
AVG Volume
131.84K
Trailing/Forward PE
-0.29/-
PEG ratio
0.01
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
NASDAQUS
Net Income (USD)
-30M-20M-10M02017201820192020202320242025
BCTXZ Net Income (USD) by year
PeriodNet Income (USD)
2025-26.29M
2024-4.95M
2023-20.4M
2020-4.92M
2019-5.85M
2018-5.42M
2017-3.22M
Operating Income (USD)
-40M-30M-20M-10M02017201820192020202320242025
BCTXZ Operating Income (USD) by year
PeriodOperating Income (USD)
2025-27.18M
2024-33.13M
2023-23.25M
2020-4.82M
2019-6.28M
2018-4.98M
2017-3.21M
EBITDA (USD)
-40M-30M-20M-10M02017201820192020202320242025
BCTXZ EBITDA (USD) by year
PeriodEBITDA (USD)
2025-26.94M
2024-33.04M
2023-23.24M
2020-4.8M
2019-6.24M
2018-4.96M
2017-3.19M
Cash Flows (USD)
-30M-20M-10M02017201820192020202320242025
BCTXZ Cash Flows (USD) by year
PeriodCash Flows (USD)
2025-28.17M
2024-16.99M
2023-23.82M
2020-1.55M
2019-5.09M
2018-4.96M
2017-1.91M
EPS (USD)
-150000-100000-5000002017201820192020202320242025
BCTXZ EPS (USD) by year
PeriodEPS (USD)
2025-76.66
2024-174.11
2023-196.52
2020-683.45
2019-117849.49
2018-2292.46
2017-1172.15
Expenses (USD)
010M20M30M40MR&DSG&ACapex2017201820192020202320242025
BCTXZ Expenses (USD) by year
PeriodExpenses (USD)
202527.16M
202433.49M
202323.24M
20204.8M
20196.24M
20184.96M
20173.21M
Cash & Debt (USD)
010M20M30MCashShort Term Debt2017201820192020202320242025
BCTXZ Cash & Debt (USD) by year
PeriodCash & Debt (USD)
202517.93M
2024858.21K
202321.16M
202026.09K
2019192.83K
20182.28M
20172.01M
Debt ratios
-0.200.20.40.62020202320242025
BCTXZ Debt ratios by year
PeriodDebt ratios
20250.2
20240.01
20230.54
2020-0.01
Return on Capital
-500%0%500%1000%2017201820192020202320242025
BCTXZ Return on Capital by year
PeriodReturn on Capital
2025-151.15%
2024185.06%
2023542.33%
2020111.48%
2019691.18%
2018-440.06%
2017-344.1%
Shares Outstanding
0500K1M1.5M2M2017201820192020202320242025
BCTXZ Shares Outstanding by year
PeriodShares Outstanding
20251.88M
2024120.18K
2023106.54K
20204.81K
20194.36K
20183.53K
20172.35K
Book Value Per Share (USD)
-1000-50005002017201820192020202320242025
BCTXZ Book Value Per Share (USD) by year
PeriodBook Value Per Share (USD)
20259.23
2024-22.24
2023-35.31
2020-917.68
2019-193.85
2018348.57
2017397.22
Total Assets (USD)
010M20M30M2017201820192020202320242025
BCTXZ Total Assets (USD) by year
PeriodTotal Assets (USD)
202521.72M
20245.85M
202327.05M
2020641.27K
2019546.01K
20182.98M
20172.04M
Employee Count
010203020212022202320242025
BCTXZ Employee Count by year
PeriodEmployee Count
202522
202417
202311
202211
20212
Free Cash Flow Yield
-50000%-40000%-30000%-20000%-10000%0%med -7980.22%Jun 25Aug 25Nov 25Jan 26Apr 26Jul 26Sep 26
BCTXZ Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 26-3282.1%
Sep 26-2962.09%
Sep 26-2307.23%
Aug 26-3161.75%
Aug 26-4065.11%
Aug 26-3880.33%
Aug 26-4785.17%
Jul 26-4747.91%
Jul 26-4281.21%
Jul 26-4272.64%
Jul 26-4272.64%
Jul 26-4742.63%
Jun 26-13829.82%
Jun 26-13864.53%
Jun 26-13829.82%
Jun 26-13899.41%
May 26-13812.53%
May 26-13812.53%
May 26-13829.82%
May 26-12291.47%
May 26-11755.35%
Apr 26-10523.84%
Apr 26-7748.97%
Apr 26-7366.68%
Apr 26-10045.48%
Mar 26-11808.05%
Mar 26-13371.48%
Mar 26-9314.6%
Mar 26-10586.52%
Feb 26-9158.99%
Feb 26-9164.45%
Feb 26-10233.64%
Feb 26-8771.69%
Jan 26-8068.57%
Jan 26-9303.31%
Jan 26-7675.23%
Jan 26-5685.36%
Jan 26-6265.49%
Dec 25-4984.17%
Dec 25-3833.97%
Dec 25-4146.56%
Dec 25-3867.69%
Nov 25-3996.93%
Nov 25-5191.84%
Nov 25-3924.54%
Nov 25-4984.17%
Oct 25-3733.46%
Oct 25-3251.25%
Oct 25-3603.88%
Oct 25-3338.36%
Oct 25-3324.26%
Sep 25-23468.41%
Sep 25-30923.09%
Sep 25-31668.22%
Sep 25-34585.03%
Aug 25-41044.07%
Aug 25-29868.89%
Aug 25-26295.14%
Aug 25-24446.26%
Aug 25-23476.8%
Jul 25-18801.59%
Jul 25-18780.1%
Jul 25-13139.68%
Jul 25-6199.2%
Jun 25-7744.36%
Jun 25-8123.99%
Jun 25-8382.02%
Jun 25-7891.88%
May 25-7533.15%
May 25-7744.36%
May 25-8204.43%
May 25-8815.39%
May 25-7022.43%
Apr 25-6325.55%
Price to Book
00.050.10.15med 0.03Jun 25Aug 25Nov 25Jan 26Apr 26Jul 26Sep 26
BCTXZ Price to Book by year
PeriodPrice to Book
Sep 260.04
Sep 260.04
Sep 260.06
Aug 260.04
Aug 260.03
Aug 260.03
Aug 260.03
Jul 260.03
Jul 260.03
Jul 260.03
Jul 260.03
Jul 260.03
Jun 260.01
Jun 260.01
Jun 260.01
Jun 260.01
May 260.01
May 260.01
May 260.01
May 260.01
May 260.01
Apr 260.01
Apr 260.01
Apr 260.01
Apr 260.01
Mar 260.03
Mar 260.02
Mar 260.03
Mar 260.03
Feb 260.03
Feb 260.03
Feb 260.03
Feb 260.04
Jan 260.04
Jan 260.03
Jan 260.04
Jan 260.05
Jan 260.05
Dec 250.03
Dec 250.04
Dec 250.04
Dec 250.04
Nov 250.04
Nov 250.03
Nov 250.04
Nov 250.03
Oct 250.04
Oct 250.05
Oct 250.04
Oct 250.05
Oct 250.05
Sep 250.01
Sep 250.01
Sep 250.01
Sep 250.01
Aug 250.01
Aug 250.01
Aug 250.01
Aug 250.01
Aug 250.01
Jul 250.01
Jul 250.01
Jul 250.02
Jul 250.03
Jun 250.09
Jun 250.09
Jun 250.08
Jun 250.09
May 250.09
May 250.09
May 250.08
May 250.08
May 250.1
Apr 250.11
BriaCell Therapeutics Corp. Warrant
BCTXZ
Stockpicker

Video analysis: BCTXZ

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.